Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma × Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Papillomavirus Infections 11 Neoplasms 9 Uterine Cervical Neoplasms 8 Breast Neoplasms 7 Condylomata Acuminata 5 Melanoma 4 Anus Neoplasms 4 Vulvar Neoplasms 3 Uterine Cervical Dysplasia 3 Lung Neoplasms 3 Vaginal Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Neuroblastoma 2 Neoplasm Metastasis 2 Influenza, Human 2 HIV Infections 2 Glioma 2 Glioblastoma 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Wilms Tumor 1 Whooping Cough 1 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Tetanus 1 Squamous Cell Carcinoma of Head and Neck 1 Spondylitis, Ankylosing 1 Small Cell Lung Carcinoma 1

Interventions

Cisplatin 46 Carboplatin 43 pembrolizumab 39 Paclitaxel 38 Gemcitabine 27 Radiotherapy 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 18 Radiotherapy, Intensity-Modulated 17 Docetaxel 17 Specimen Handling 15 Nivolumab 15 Cetuximab 15 Cyclophosphamide 14 durvalumab 13 Fluorouracil 13 130-nm albumin-bound paclitaxel 10 Platinum 9 Bevacizumab 9 osimertinib 8 Sunitinib 8 Sorafenib 8 Radiation 8 Oxaliplatin 8 Irinotecan 8 Everolimus 8 Capecitabine 8 1,2-diaminocyclohexaneplatinum II citrate 8 Ipilimumab 7 Drug Therapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00684294 2020-03-02

Auto TAG

Mary Crowley Medical Research Center

Phase 1 Terminated

Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡